Consolidated Balance Sheets - USD ($) $ in Thousands		Sep. 30, 2022		Dec. 31, 2021
Assets
Cash and cash equivalents	[1]	$ 24,754		$ 64,482
Federal funds sold		73,448		60,002
Investment securities		48,354		44,772
Equity investments		10,670		9,726
Loans		1,855,510		1,488,924
Allowance for loan losses		(61,535)	[2]	(50,166)
Net loans receivable		1,793,975		1,438,758
Goodwill		150,803		150,803
Loan collateral in process of foreclosure	[3]	24,331		37,430
Intangible assets, net		22,398		23,480
Property, equipment, and right-of-use lease asset, net		12,636		11,762
Accrued interest receivable		11,959		10,621
Income tax receivable		3,420		833
Other assets		22,793		20,388
Total assets		2,199,541		1,873,057
Liabilities
Deposits	[4]	1,555,832		1,250,880
Long-term debt	[5]	219,448		219,973
Deferred tax liabilities, net		26,132		18,210
Operating lease liabilities		8,580		9,053
Accrued interest payable		3,432		3,395
Accounts payable and accrued expenses	[6]	26,228		15,718
Total liabilities		1,839,652		1,517,229
Commitments and contingencies
Stockholders’ equity
Preferred stock (1,000,000 shares of $0.01 par value stock authorized-none outstanding)		0		0
Common stock (50,000,000 shares of $0.01 par value stock authorized - 28,529,993 shares at September 30, 2022 and 28,124,629 shares at December 31, 2021 issued)		285		281
Additional paid in capital		282,681		280,038
Treasury stock (5,344,923 shares at September 30, 2022 and 2,951,243 shares at December 31, 2021)		(43,741)		(24,919)
Accumulated other comprehensive income (loss)		(3,562)		1,034
Retained earnings		55,438		30,606
Total stockholders’ equity		291,101		287,040
Non-controlling interest in consolidated subsidiaries		68,788		68,788
Total equity		359,889		355,828
Total liabilities and equity		$ 2,199,541		$ 1,873,057
Number of shares outstanding		23,185,070		25,173,386
Book value per share		$ 12.56		$ 11.40

[1] Includes no restricted cash requirement as of September 30, 2022 and $3.0 million as of December 31, 2021.

[2] As of September 30, 2022 and September 30, 2021, there were no allowance for loan losses and net charge-offs related to the strategic partnership loans.

[3] Includes financed sales of this collateral to third parties that are reported separately from the loan portfolio, of $7.8 million as of September 30, 2022 and $7.4 million as of December 31, 2021

[4] Includes $3.9 million and $3.2 million of deferred financing costs as of September 30, 2022 and December 31, 2021. Refer to Note 5 for more details.

[5] Includes $3.3 million and $4.0 million of deferred financing costs as of September 30, 2022 and December 31, 2021. Refer to Note 5 for more details.

[6] Includes the short-term portion of lease liabilities of $2.1 million and $2.2 million as of September 30, 2022 and December 31, 2021. Refer to Note 6 for more details.